Crossref journal-article
Wiley
Journal of Neurochemistry (311)
Abstract

AbstractParkinson’s disease (PD) is characterized by accumulation of α‐synuclein (α‐syn) and degeneration of neuronal populations in cortical and subcortical regions. Mitochondrial dysfunction has been considered a potential unifying factor in the pathogenesis of the disease. Mutations in genes linked to familial forms of PD, including SNCA encoding α‐syn and Pten‐induced putative kinase 1 (PINK1), have been shown to disrupt mitochondrial activity. We investigated the mechanisms through which mutant Pink1 might disrupt mitochondrial function in neuronal cells with α‐syn accumulation. For this purpose, a neuronal cell model of PD was infected with virally‐delivered Pink1, and was analyzed for cell survival, mitochondrial activity and calcium flux. Mitochondrial morphology was analyzed by confocal and electron microscopy. These studies showed that mutant (W437X) but not wildtype Pink1 exacerbated the alterations in mitochondrial function promoted by mutant (A53T) α‐syn. This effect was associated with increased intracellular calcium levels. Co‐expression of both mutant Pink1 and α‐syn led to alterations in mitochondrial structure and neurite outgrowth that were partially ameliorated by treatment with cyclosporine A, and completely restored by treatment with the mitochondrial calcium influx blocker Ruthenium Red, but not with other cellular calcium flux blockers. Our data suggest a role for mitochondrial calcium influx in the mechanisms of mitochondrial and neuronal dysfunction in PD. Moreover, these studies support an important function for Pink1 in regulating mitochondrial activity under stress conditions.

Bibliography

Marongiu, R., Spencer, B., Crews, L., Adame, A., Patrick, C., Trejo, M., Dallapiccola, B., Valente, E. M., & Masliah, E. (2009). Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson’s disease by disturbing calcium flux. Journal of Neurochemistry, 108(6), 1561–1574. Portico.

Authors 9
  1. Roberta Marongiu (first)
  2. Brian Spencer (additional)
  3. Leslie Crews (additional)
  4. Anthony Adame (additional)
  5. Christina Patrick (additional)
  6. Margarita Trejo (additional)
  7. Bruno Dallapiccola (additional)
  8. Enza Maria Valente (additional)
  9. Eliezer Masliah (additional)
References 92 Referenced 127
  1. 10.1038/nrn1868
  2. 10.1097/WNR.0b013e3280115185
  3. 10.1038/81834
  4. 10.1212/01.wnl.0000167546.39375.82
  5. 10.1007/PL00007758
  6. 10.1523/JNEUROSCI.23-12-04858.2003
  7. 10.1016/S0165-0270(00)00340-X
  8. 10.1016/j.pneurobio.2006.09.003
  9. 10.1016/j.expneurol.2007.08.006
  10. 10.1038/3311
  11. 10.1073/pnas.97.2.571
  12. 10.1016/j.expneurol.2007.05.022
  13. 10.1016/S0006-3495(03)75079-6
  14. 10.1523/JNEUROSCI.0066-08.2008
  15. 10.1042/bj3410233
  16. 10.1016/j.tcb.2003.12.002
  17. 10.1126/science.1101738
  18. 10.4161/auto.1.3.2017
  19. 10.1523/JNEUROSCI.2617-07.2007
  20. 10.1016/S0896-6273(03)00568-3
  21. 10.1073/pnas.172514599
  22. 10.1016/j.bbrc.2005.09.178
  23. 10.1073/pnas.0803998105
  24. 10.1074/jbc.M710012200
  25. 10.1016/0962-8924(94)90069-8
  26. 10.1385/JMN:18:3:229
  27. 10.1523/JNEUROSCI.0719-07.2007
  28. 10.1111/j.1471-4159.2006.03803.x
  29. 10.1016/S0896-6273(02)00682-7
  30. 10.1126/science.281.5381.1309
  31. 10.1073/pnas.0705363105
  32. 10.1074/jbc.M208046200
  33. 10.1006/bbrc.1997.6978
  34. 10.1046/j.1471-4159.2003.01791.x
  35. 10.1002/ana.20251
  36. 10.1001/archneur.63.6.833
  37. 10.1016/0304-3940(85)90580-4
  38. 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F
  39. 10.1016/S0002-9440(10)64553-1
  40. 10.1080/13550280490520961
  41. 10.1126/science.6823561
  42. 10.1046/j.1471-4159.2001.00149.x
  43. 10.1073/pnas.132197599
  44. 10.1074/jbc.M011121200
  45. 10.1097/WNR.0b013e3282f03db4
  46. 10.1038/sj.emboj.7600451
  47. 10.1523/JNEUROSCI.4308-05.2006
  48. 10.1074/jbc.M209020200
  49. 10.1126/science.287.5456.1265
  50. 10.1093/jnen/60.4.357
  51. 10.1111/j.1474-9726.2007.00275.x
  52. 10.1152/physrev.1990.70.2.391
  53. 10.1016/0006-291X(89)91141-8
  54. 10.1038/90976
  55. 10.1016/S0065-3527(00)55020-9
  56. 10.1074/jbc.274.14.9843
  57. 10.1152/physrev.2000.80.1.315
  58. 10.1016/0014-5793(80)80806-4
  59. 10.1038/90116
  60. 10.1002/ajmg.1425
  61. 10.1038/4411058a
  62. 10.1093/brain/awm318
  63. 10.1038/nn884
  64. 10.1007/s00018-008-7589-1
  65. 10.1074/jbc.M505143200
  66. {'key': 'e_1_2_7_67_1', 'first-page': '2190', 'article-title': 'The autophagy‐related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice', 'volume': '118', 'author': 'Pickford F.', 'year': '2008', 'journal-title': 'J. Clin. Invest.'} / J. Clin. Invest. / The autophagy‐related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice by Pickford F. (2008)
  67. 10.1038/sj.cdd.4401697
  68. 10.1371/journal.pbio.0050172
  69. 10.1093/hmg/11.9.1107
  70. 10.1111/j.1471-4159.2006.03788.x
  71. 10.1002/jnr.1247
  72. 10.1038/nature05291
  73. 10.1016/S0140-6736(89)92366-0
  74. 10.1038/249224a0
  75. 10.1007/BF01923509
  76. 10.1093/hmg/ddi377
  77. 10.1093/hmg/ddi396
  78. 10.1016/S0014-5793(00)01563-5
  79. 10.1038/42166
  80. {'key': 'e_1_2_7_81_1', 'first-page': '367', 'article-title': 'Abnormal accumulation of NACP/α‐synuclein in neurodegenerative disorders', 'volume': '152', 'author': 'Takeda A.', 'year': '1998', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Abnormal accumulation of NACP/α‐synuclein in neurodegenerative disorders by Takeda A. (1998)
  81. 10.1006/mcne.2000.0923
  82. 10.1002/humu.20507
  83. 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
  84. 10.1126/science.1096284
  85. 10.1007/s11910-007-0068-5
  86. 10.1021/bi0121353
  87. 10.1016/S0304-3940(97)00891-4
  88. 10.2174/0929867033457160
  89. 10.1074/jbc.M300227200
  90. 10.1073/pnas.0711845105
  91. 10.1016/j.neulet.2004.05.118
  92. 10.1111/j.1471-4159.2006.03767.x
Dates
Type When
Created 16 years, 7 months ago (Jan. 24, 2009, 10:37 a.m.)
Deposited 1 year, 11 months ago (Sept. 28, 2023, 8:59 p.m.)
Indexed 2 days, 17 hours ago (Sept. 3, 2025, 6:49 a.m.)
Issued 16 years, 6 months ago (Feb. 23, 2009)
Published 16 years, 6 months ago (Feb. 23, 2009)
Published Online 16 years, 6 months ago (Feb. 23, 2009)
Published Print 16 years, 6 months ago (March 1, 2009)
Funders 0

None

@article{Marongiu_2009, title={Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson’s disease by disturbing calcium flux}, volume={108}, ISSN={1471-4159}, url={http://dx.doi.org/10.1111/j.1471-4159.2009.05932.x}, DOI={10.1111/j.1471-4159.2009.05932.x}, number={6}, journal={Journal of Neurochemistry}, publisher={Wiley}, author={Marongiu, Roberta and Spencer, Brian and Crews, Leslie and Adame, Anthony and Patrick, Christina and Trejo, Margarita and Dallapiccola, Bruno and Valente, Enza Maria and Masliah, Eliezer}, year={2009}, month=feb, pages={1561–1574} }